Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vericel Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
VCEL
Nasdaq
2836
https://vcel.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vericel Corp
Vericel Corporation (NASDAQ:VCEL) On The Verge Of Breaking Even
- Apr 13th, 2024 12:24 pm
Director ZERBE ROBERT L MD Sells Shares of Vericel Corp (VCEL)
- Mar 29th, 2024 11:01 pm
Land Developer And A Specialty Medical Stock Burst Into Buy Zones
- Mar 28th, 2024 5:48 pm
Vericel Corp President and CEO Dominick Colangelo Sells 35,000 Shares
- Mar 15th, 2024 11:00 pm
US$52.07 - That's What Analysts Think Vericel Corporation (NASDAQ:VCEL) Is Worth After These Results
- Mar 3rd, 2024 12:53 pm
Vericel Full Year 2023 Earnings: EPS Beats Expectations
- Mar 2nd, 2024 12:48 pm
Vericel Corporation (NASDAQ:VCEL) Q4 2023 Earnings Call Transcript
- Mar 1st, 2024 2:30 pm
Vericel Corporation (NASDAQ:VCEL) Shares Could Be 48% Below Their Intrinsic Value Estimate
- Mar 1st, 2024 11:44 am
Q4 2023 Vericel Corp Earnings Call
- Mar 1st, 2024 4:37 am
Vericel Corporation (VCEL) Q4 Earnings Beat Estimates
- Feb 29th, 2024 2:05 pm
Vericel Corp (VCEL) Reports Robust Revenue and EBITDA Growth in Q4 and Full-Year 2023
- Feb 29th, 2024 1:32 pm
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
- Feb 29th, 2024 12:55 pm
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
- Feb 27th, 2024 1:30 pm
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
- Feb 26th, 2024 4:29 pm
Are You Looking for a Top Momentum Pick? Why Vericel Corporation (VCEL) is a Great Choice
- Feb 22nd, 2024 5:00 pm
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q4 Earnings Expected to Decline
- Feb 22nd, 2024 3:00 pm
Vericel Corporation (VCEL) to Report Q4 Results: Wall Street Expects Earnings Growth
- Feb 15th, 2024 3:00 pm
Vericel Corporation (VCEL) is on the Move, Here's Why the Trend Could be Sustainable
- Feb 15th, 2024 1:50 pm
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
- Feb 15th, 2024 1:30 pm
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Feb 5th, 2024 1:30 pm
Scroll